{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T16:20:11Z","timestamp":1789057211729,"version":"build-2803163510"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T00:00:00Z","timestamp":1729555200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T00:00:00Z","timestamp":1729555200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP21fk0108615"],"award-info":[{"award-number":["JP21fk0108615"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP22fk0108509"],"award-info":[{"award-number":["JP22fk0108509"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-75038-4","type":"journal-article","created":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T07:02:48Z","timestamp":1729580568000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Improved efficacy of SARS-CoV-2 isolation from COVID-19 clinical specimens using VeroE6 cells overexpressing TMPRSS2 and human ACE2"],"prefix":"10.1038","volume":"14","author":[{"given":"Hitomi","family":"Kinoshita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsukasa","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yudai","family":"Kuroda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaya","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norio","family":"Ohmagari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Tokita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phu Hoang Anh","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Souichi","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shizuko","family":"Harada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Kanno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichiro","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masumichi","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuya","family":"Shirato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikuyo","family":"Takayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoya","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Ebihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadaki","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuetsu","family":"Fukushi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,22]]},"reference":[{"key":"75038_CR1","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","volume":"579","author":"P Zhou","year":"2020","unstructured":"Zhou, P. et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579, 270\u2013273. https:\/\/doi.org\/10.1038\/s41586-020-2012-7 (2020).","journal-title":"Nature"},{"key":"75038_CR2","doi-asserted-by":"publisher","unstructured":"Coronaviridae Study Group of the International Committee on Taxonomy of Viruses. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol 5, 536\u2013544. https:\/\/doi.org\/10.1038\/s41564-020-0695-z (2020).","DOI":"10.1038\/s41564-020-0695-z"},{"key":"75038_CR3","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s41586-022-04411-y","volume":"603","author":"R Viana","year":"2022","unstructured":"Viana, R. et al. Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa. Nature 603, 679\u2013686. https:\/\/doi.org\/10.1038\/s41586-022-04411-y (2022).","journal-title":"Nature"},{"key":"75038_CR4","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1056\/NEJMc2206576","volume":"387","author":"NP Hachmann","year":"2022","unstructured":"Hachmann, N. P. et al. Neutralization escape by SARS-CoV-2 omicron subvariants BA.2.12.1, BA.4, and BA.5. N. Engl. J. Med. 387, 86\u201388. https:\/\/doi.org\/10.1056\/NEJMc2206576 (2022).","journal-title":"N. Engl. J. Med."},{"key":"75038_CR5","doi-asserted-by":"publisher","first-page":"e2381","DOI":"10.1002\/rmv.2381","volume":"32","author":"LB Shrestha","year":"2022","unstructured":"Shrestha, L. B., Foster, C., Rawlinson, W., Tedla, N. & Bull, R. A. Evolution of the SARS-CoV-2 omicron variants BA.1 to BA.5: Implications for immune escape and transmission. Rev. Med. Virol. 32, e2381. https:\/\/doi.org\/10.1002\/rmv.2381 (2022).","journal-title":"Rev. Med. Virol."},{"key":"75038_CR6","unstructured":"WHO. Statement on the fifteenth meeting of the International Health Regulations (2005) emergency committee regarding the coronavirus disease (COVID-19) pandemic (2023) World Health Organization. https:\/\/www.who.int\/news\/item\/05-05-2023-statement-on-the-fifteenth-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-coronavirus-disease-(covid-19)-pandemic?adgroupsurvey=%7Badgroupsurvey%7D&gclid=EAIaIQobChMI4Ojtsdbe_gIVjQRyCh07igt4EAAYASACEgJ9pfD_BwE&fbclid=IwAR2M8EAyiSrAodhK9p-X582nHkP2AigpSX8pYIsLsPwqYh4SG26RGokGe7E (2023)."},{"key":"75038_CR7","doi-asserted-by":"publisher","first-page":"2859","DOI":"10.1097\/JS9.0000000000000521","volume":"109","author":"K Cheng","year":"2023","unstructured":"Cheng, K. et al. WHO declares the end of the COVID-19 global health emergency: lessons and recommendations from the perspective of ChatGPT\/GPT-4. Int. J. Surg. 109, 2859\u20132862. https:\/\/doi.org\/10.1097\/JS9.0000000000000521 (2023).","journal-title":"Int. J. Surg."},{"key":"75038_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(24)00155-5","author":"DL Wannigama","year":"2024","unstructured":"Wannigama, D. L. et al. Increased faecal shedding in SARS-CoV-2 variants BA.2.86 and JN.1. Lancet Infect. Dis. https:\/\/doi.org\/10.1016\/S1473-3099(24)00155-5 (2024).","journal-title":"Lancet Infect. Dis."},{"key":"75038_CR9","unstructured":"WHO. Laboratory testing for 2019 novel coronavirus (2019-nCoV) in suspected human cases. Available:  https:\/\/www.who.int\/publications\/i\/item\/10665-331501 (2020)."},{"key":"75038_CR10","doi-asserted-by":"publisher","first-page":"304","DOI":"10.7883\/yoken.JJID.2020.061","volume":"73","author":"K Shirato","year":"2020","unstructured":"Shirato, K. et al. Development of genetic diagnostic methods for detection for novel coronavirus 2019(nCoV-2019) in Japan. Jpn. J. Infect. Dis. 73, 304\u2013307. https:\/\/doi.org\/10.7883\/yoken.JJID.2020.061 (2020).","journal-title":"Jpn. J. Infect. Dis."},{"key":"75038_CR11","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1099\/vir.0.81749-0","volume":"87","author":"X Ren","year":"2006","unstructured":"Ren, X. et al. Analysis of ACE2 in polarized epithelial cells: surface expression and function as receptor for severe acute respiratory syndrome-associated coronavirus. J. Gen. Virol. 87, 1691\u20131695. https:\/\/doi.org\/10.1099\/vir.0.81749-0 (2006).","journal-title":"J. Gen. Virol."},{"key":"75038_CR12","doi-asserted-by":"publisher","first-page":"7001","DOI":"10.1073\/pnas.2002589117","volume":"117","author":"S Matsuyama","year":"2020","unstructured":"Matsuyama, S. et al. Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells. Proc. Natl. Acad. Sci. USA 117, 7001\u20137003. https:\/\/doi.org\/10.1073\/pnas.2002589117 (2020).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"75038_CR13","doi-asserted-by":"publisher","DOI":"10.1136\/bmjresp-2020-000830","author":"S Yamada","year":"2021","unstructured":"Yamada, S. et al. Assessment of SARS-CoV-2 infectivity of upper respiratory specimens from COVID-19 patients by virus isolation using VeroE6\/TMPRSS2 cells. BMJ Open Respir. Res.https:\/\/doi.org\/10.1136\/bmjresp-2020-000830 (2021).","journal-title":"BMJ Open Respir. Res."},{"key":"75038_CR14","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1080\/22221751.2021.2023329","volume":"11","author":"H Zhao","year":"2022","unstructured":"Zhao, H. et al. SARS-CoV-2 Omicron variant shows less efficient replication and fusion activity when compared with Delta variant in TMPRSS2-expressed cells. Emerg. Microbes Infect. 11, 277\u2013283. https:\/\/doi.org\/10.1080\/22221751.2021.2023329 (2022).","journal-title":"Emerg. Microbes Infect."},{"key":"75038_CR15","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.virol.2022.05.004","volume":"572","author":"P Kumar","year":"2022","unstructured":"Kumar, P. et al. Identification of potential COVID-19 treatment compounds which inhibit SARS Cov2 prototypic, delta and omicron variant infection. Virology 572, 64\u201371. https:\/\/doi.org\/10.1016\/j.virol.2022.05.004 (2022).","journal-title":"Virology"},{"key":"75038_CR16","doi-asserted-by":"crossref","unstructured":"Quick, J. nCoV-2019 sequencing protocol v3 (LoCost), on Version created by Josh Quick. https:\/\/protocols.io\/view\/ncov-2019-sequencing-protocol-v3-locost-bh42j8ye (2020).","DOI":"10.17504\/protocols.io.bp2l6n26rgqe\/v3"},{"key":"75038_CR17","doi-asserted-by":"crossref","unstructured":"Itokawa, K. et al, nCoV-2019 sequencing protocol for illumina. https:\/\/www.protocols.io\/view\/ncov-2019-sequencing-protocol-for-illumina-eq2ly398mgx9\/v5 (2021).","DOI":"10.17504\/protocols.io.betejeje"},{"key":"75038_CR18","unstructured":"Sasaki, N. Alt_nCov2019_primers ver_N6. https:\/\/github.com\/nasasaki\/Alt_nCov2019_primers (2022)."},{"key":"75038_CR19","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.medj.2022.02.006","volume":"3","author":"S Miyamoto","year":"2022","unstructured":"Miyamoto, S. et al. Vaccination-infection interval determines cross-neutralization potency to SARS-CoV-2 Omicron after breakthrough infection by other variants. Medicine 3, 249\u2013261. https:\/\/doi.org\/10.1016\/j.medj.2022.02.006 (2022).","journal-title":"Medicine"},{"key":"75038_CR20","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12985-021-01490-7","volume":"18","author":"H Tani","year":"2021","unstructured":"Tani, H. et al. Evaluation of SARS-CoV-2 neutralizing antibodies using a vesicular stomatitis virus possessing SARS-CoV-2 spike protein. Virol. J. 18, 16. https:\/\/doi.org\/10.1186\/s12985-021-01490-7 (2021).","journal-title":"Virol. J."},{"key":"75038_CR21","doi-asserted-by":"publisher","first-page":"12552","DOI":"10.1128\/JVI.01890-13","volume":"87","author":"K Shirato","year":"2013","unstructured":"Shirato, K., Kawase, M. & Matsuyama, S. Middle East respiratory syndrome coronavirus infection mediated by the transmembrane serine protease TMPRSS2. J. Virol. 87, 12552\u201312561. https:\/\/doi.org\/10.1128\/JVI.01890-13 (2013).","journal-title":"J. Virol."},{"key":"75038_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0289432","volume":"18","author":"G Rucker","year":"2023","unstructured":"Rucker, G., Qin, H. & Zhang, L. Structure, dynamics and free energy studies on the effect of point mutations on SARS-CoV-2 spike protein binding with ACE2 receptor. PLoS ONE 18, e0289432. https:\/\/doi.org\/10.1371\/journal.pone.0289432 (2023).","journal-title":"PLoS ONE"},{"key":"75038_CR23","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1016\/j.chom.2022.09.018","volume":"30","author":"Y Cao","year":"2022","unstructured":"Cao, Y. et al. Characterization of the enhanced infectivity and antibody evasion of Omicron BA.2.75. Cell Host Microbe 30, 1527\u20131539. https:\/\/doi.org\/10.1016\/j.chom.2022.09.018 (2022).","journal-title":"Cell Host Microbe"},{"key":"75038_CR24","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1038\/s41586-022-04474-x","volume":"603","author":"B Meng","year":"2022","unstructured":"Meng, B. et al. Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity. Nature 603, 706\u2013714. https:\/\/doi.org\/10.1038\/s41586-022-04474-x (2022).","journal-title":"Nature"},{"key":"75038_CR25","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1056\/NEJMoa2008457","volume":"382","author":"MM Arons","year":"2020","unstructured":"Arons, M. M. et al. Presymptomatic SARS-CoV-2 infections and transmission in a skilled nursing facility. N. Engl. J. Med. 382, 2081\u20132090. https:\/\/doi.org\/10.1056\/NEJMoa2008457 (2020).","journal-title":"N. Engl. J. Med."},{"key":"75038_CR26","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2020.25.32.2001483","author":"A Singanayagam","year":"2020","unstructured":"Singanayagam, A. et al. Duration of infectiousness and correlation with RT-PCR cycle threshold values in cases of COVID-19, England, January to May 2020. Euro Surveill. https:\/\/doi.org\/10.2807\/1560-7917.ES.2020.25.32.2001483 (2020).","journal-title":"Euro Surveill."},{"key":"75038_CR27","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1007\/s10096-020-03913-9","volume":"39","author":"B La Scola","year":"2020","unstructured":"La Scola, B. et al. Viral RNA load as determined by cell culture as a management tool for discharge of SARS-CoV-2 patients from infectious disease wards. Eur. J. Clin. Microbiol. Infect. Dis. 39, 1059\u20131061. https:\/\/doi.org\/10.1007\/s10096-020-03913-9 (2020).","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"75038_CR28","doi-asserted-by":"publisher","first-page":"4198","DOI":"10.1038\/s41467-023-39890-8","volume":"14","author":"S Moriyama","year":"2023","unstructured":"Moriyama, S. et al. Structural delineation and computational design of SARS-CoV-2-neutralizing antibodies against Omicron subvariants. Nat. Commun. 14, 4198. https:\/\/doi.org\/10.1038\/s41467-023-39890-8 (2023).","journal-title":"Nat. Commun."},{"key":"75038_CR29","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/s41586-020-2196-x","volume":"581","author":"R Wolfel","year":"2020","unstructured":"Wolfel, R. et al. Virological assessment of hospitalized patients with COVID-2019. Nature 581, 465\u2013469. https:\/\/doi.org\/10.1038\/s41586-020-2196-x (2020).","journal-title":"Nature"},{"key":"75038_CR30","first-page":"43","volume":"74","author":"I Yoshida","year":"2023","unstructured":"Yoshida, I. et al. Investigation of culture cells used for isolation and culture of severe acute respiratory syndrome coronavirus 2, omicron variant, isolated in Tokyo. Ann. Rep. Tokyo Metr. Inst. Public Health 74, 43\u201347 (2023).","journal-title":"Ann. Rep. Tokyo Metr. Inst. Public Health"},{"key":"75038_CR31","doi-asserted-by":"publisher","first-page":"106634","DOI":"10.1016\/j.isci.2023.106634","volume":"26","author":"DY Chen","year":"2023","unstructured":"Chen, D. Y. et al. Cell culture systems for isolation of SARS-CoV-2 clinical isolates and generation of recombinant virus. iScience 26, 106634. https:\/\/doi.org\/10.1016\/j.isci.2023.106634 (2023).","journal-title":"iScience"},{"key":"75038_CR32","doi-asserted-by":"publisher","first-page":"6773","DOI":"10.1128\/JVI.00649-15","volume":"89","author":"KJ Alfson","year":"2015","unstructured":"Alfson, K. J. et al. Particle-to-PFU ratio of Ebola virus influences disease course and survival in cynomolgus macaques. J Virol 89, 6773\u20136781. https:\/\/doi.org\/10.1128\/JVI.00649-15 (2015).","journal-title":"J Virol"},{"key":"75038_CR33","doi-asserted-by":"publisher","DOI":"10.1128\/mSphere.00401-17","author":"KJ Alfson","year":"2018","unstructured":"Alfson, K. J. et al. A single amino acid change in the marburg virus glycoprotein arises during serial cell culture passages and attenuates the virus in a macaque model of disease. mSphere. https:\/\/doi.org\/10.1128\/mSphere.00401-17 (2018).","journal-title":"mSphere."},{"key":"75038_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/v14020383","author":"T Bhat","year":"2022","unstructured":"Bhat, T., Cao, A. & Yin, J. Virus-like Particles: Measures and biological functions. Viruses. https:\/\/doi.org\/10.3390\/v14020383 (2022).","journal-title":"Viruses."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-75038-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-75038-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-75038-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T07:05:54Z","timestamp":1729580754000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-75038-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,22]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["75038"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-75038-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,22]]},"assertion":[{"value":"10 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All protocols and procedures involving human samples and subjects were approved by the research ethics committee of the NCGM (file no. NCGM-S-004202-12) and the NIID (file no. 1691 and 1807).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"24858"}}